Drug delivery strategies for the treatment of malignant gliomas

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 299-310

  Allhenn, Daniela ^a   Shetab Boushehri, Maryam Alsadat ^a   Lamprecht, Alf ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Endogenous transport systems; Gliomas; Localized drug delivery; Polymeric implants; Systemic drug delivery

Indexed keywords

6 O BENZYLGUANINE; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAMPTOTHECIN; CAPECITABINE; CARBOPLATIN; CARMUSTINE; CELECOXIB; CINTREDEKIN BESUDOTOX; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; IRINOTECAN; LIPOSOME; MITOXANTRONE; NANOCARRIER; NITROSOUREA DERIVATIVE; PACLITAXEL; SURAMIN; TAMOXIFEN DERIVATIVE; TEMOZOLOMIDE; TRABEDERSEN; VATALANIB; VINCRISTINE;

ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN TUMOR; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICAL MODIFICATION; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG PENETRATION; DRUG POTENTIATION; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HUMAN; IMMUNOTHERAPY; IMPLANT; MICROCARRIER CULTURE; MICROCHIP ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUSTAINED DRUG RELEASE; TREATMENT PLANNING; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GLIOMA; HUMANS;

EID: 84865281604     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.025     Document Type: Review

References (151)

1. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol. Dis. 37 2010 13 25
2. U. Akbar, T. Jones, J. Winestone, M. Michael, A. Shukla, Y. Sun, and C. Duntsch Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection J. Neurooncol. 94 2009 203 212
3. E. Allard, C. Passirani, and J.P. Benoit Convection-enhanced delivery of nanocarriers for the treatment of brain tumors Biomaterials 30 2009 2302 2318
4. E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres, G. Jaouen, and J.P. Benoit Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas J. Control. Release 130 2008 146 153
5. Angiochem-Inc, 2012. A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma, ClinicalTrials.gov, National Library of Medicine (US), Bethesda: National Library of Medicine (US). Available from: http://clinicaltrials.gov/ct2/show/NCT00539344 NLM, Identifier: NCT00539344 (cited 25.04.12).
6. N. Asano, K. Kitamura, Y. Seo, K. Mukai, T. Soga, H. Hondo, and K. Matsumoto Spinal cord glioblastoma multiforme with intracranial dissemination - case report Neurol. Med. Chir. (Tokyo) 30 1990 489 494
7. G.W. Astary, S. Kantorovich, P.R. Carney, T.H. Mareci, and M. Sarntinoranont Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo J. Neurosci. Methods 187 2010 129 137
8. O. AyubK Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid The Lancet 282 1963 983 984
9. S. Bakhshi, and R.B. North Implantable pumps for drug delivery to the brain J. Neurooncol. 26 1995 133 139
10. T. Barichello, J.S. Pereira, G.D. Savi, J.S. Generoso, A.L. Cipriano, C. Silvestre, F. Petronilho, F. Dal-Pizzol, M.C. Vilela, and A.L. Teixeira A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis J. Neuroimmunol. 233 2011 12 17
11. R.T. Bartus, P. Snodgrass, J. Marsh, M. Agostino, A. Perkins, and D.F. Emerich Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival J. Pharmacol. Exp. Ther. 293 2000 903 911
12. A. Beduneau, P. Saulnier, and J.P. Benoit Active targeting of brain tumors using nanocarriers Biomaterials 28 2007 4947 4967
13. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr. Rev. 30 2009 586 623
14. U. Bickel, T. Yoshikawa, and W.M. Pardridge Delivery of peptides and proteins through the blood-brain barrier Adv. Drug Deliv. Rev. 46 2001 247 279
15. R.J. Boado, and W.M. Pardridge The Trojan Horse Liposome Technology for nonviral gene transfer across the blood-brain barrier J. Drug Deliv. 2011 2011 296151
16. R.H. Bobo, D.W. Laske, A. Akbasak, P.F. Morrison, R.L. Dedrick, and E.H. Oldfield Convection-enhanced delivery of macromolecules in the brain Proc. Natl. Acad. Sci. U.S.A. 91 1994 2076 2080
17. N. Bodor, and P. Buchwald Drug targeting via retrometabolic approaches Pharmacol. Ther. 76 1997 1 27
18. N. Bodor, H.H. Farag, M.D. Barros, W.M. Wu, and P. Buchwald In vitro and in vivo evaluations of dihydroquinoline- and dihydroisoquinoline-based targetor moieties for brain-specific chemical delivery systems J. Drug Target. 10 2002 63 71
19. A. Boiardi, M. Eoli, A. Pozzi, A. Salmaggi, G. Broggi, and A. Silvani Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients Ital. J. Neurol. Sci. 20 1999 43 48
20. A. Boiardi, A. Salmaggi, A. Pozzi, G. Broggi, and A. Silvani Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data J. Neurooncol. 27 1996 157 162
21. H. Brem, and R. Langer Polymer-based drug delivery to the brain Sci. Med. 3 1996 52 61
22. H. Brem, M.S. Mahaley Jr.; N.A. Vick, K.L. Black, S.C. Schold Jr.; P.C. Burger, A.H. Friedman, I.S. Ciric, T.W. Eller, and J.W. Cozzens Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas J. Neurosurg. 74 1991 441 446
23. H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, N.A. Vick, K. Black, M. Sisti, S. Brem, and G. Mohr Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group Lancet 345 1995 1008 1012
24. G.L. Brown, M. Echley, and K.A. Wargo A review of glioblastoma multiforme US Pharmacist 35 2010 3 10
25. M.A. Cahan, K.A. Walter, O.M. Colvin, and H. Brem Cytotoxicity of taxol in vitro against human and rat malignant brain tumors Cancer Chemother. Pharmacol. 33 1994 441 444
26. Cbrtus I. Hinsdale, CBRTUS Statistical Report: Primary Brain Tumors and Central Nervous System Tumors diagnosed in the United States in 2004-2007 2011 http://www.cbtrus.org/contactus/contactus.html
27. S.R. Chandana, S. Movva, M. Arora, and T. Singh Primary brain tumors in adults Am. Fam. Physician 77 2008 1423 1430
28. W.F. Chandler, H.S. Greenberg, W.D. Ensminger, R.F. Diaz, L.R. Junck, T.W. Hood, S.S. Gebarski, and M.A. Page Use of implantable pump systems for intraarterial, intraventricular and intratumoral treatment of malignant brain tumors Ann. N.Y. Acad. Sci. 531 1988 206 212
29. Y. Cirpanli, E. Allard, C. Passirani, E. Bilensoy, L. Lemaire, S. Calis, and J.P. Benoit Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model Int. J. Pharm. 2010
30. J. Clarke, N. Butowski, and S. Chang Recent advances in therapy for glioblastoma Arch. Neurol. 67 2010 279 283
31. E.M. Cornford, D. Young, J.W. Paxton, G.J. Finlay, W.R. Wilson, and W.M. Pardridge Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain Cancer Res. 52 1992 138 143
32. A. Di Paolo, and G. Bocci Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification Curr. Oncol. Rep. 9 2007 109 114
33. F. DiMeco, K.W. Li, B.M. Tyler, A.S. Wolf, H. Brem, and A. Olivi Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats J. Neurosurg. 97 2002 1173 1178
34. J. Drappatz, A.J. Brenner, S. Rosenfeld, M.D. Groves, T. Mikkelsen, D. Schiff, J. Sarantopoulos, E. Wong, P.Y. Wen, and J. Castaigne ANG1005: Results of a phase I study in patients with recurrent malignant glioma J. Clin. Oncol. 28 2010 http://meeting.ascopubs.org/cgi/content/abstract/28/15-suppl/2009?sid= 2003b2916c2002f-2284c-2004bc2004-2009c2024-f8435a2176a2099
35. N.L. Elstad, and K.D. Fowers OncoGel (ReGel/paclitaxel) - clinical applications for a novel paclitaxel delivery system Adv. Drug Deliv. Rev. 61 2009 785 794
36. H.H. Engelhard The role of interstitial BCNU chemotherapy in the treatment of malignant glioma Surg. Neurol. 53 2000 458 464
37. D. Fortin, A. Desjardins, A. Benko, T. Niyonsega, and M. Boudrias Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience Cancer 103 2005 2606 2615
38. L.K. Fung, M. Shin, B. Tyler, H. Brem, and W.M. Saltzman Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1- nitrosourea in the rat brain Pharm. Res. 13 1996 671 682
39. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol. Dis. 37 2010 48 57
40. G.L. Gallia, S. Brem, and H. Brem Local treatment of malignant brain tumors using implantable chemotherapeutic polymers J. Natl. Compr. Canc. Netw. 3 2005 721 728
41. V. Ganapathy, M. Thangaraju, and P.D. Prasad Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond Pharmacol. Ther. 121 2009 29 40
42. E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.P. Benoit A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats Mol. Cancer Ther. 5 2006 1710 1722
43. J.S. Garfield Neurosurgical aspects of supratentorial malignant gliomas Proc. R. Soc. Med. 69 1976 53 55
44. C. Giussani, G. Carrabba, M. Pluderi, V. Lucini, M. Pannacci, D. Caronzolo, F. Costa, M. Minotti, G. Tomei, R. Villani, R.S. Carroll, A. Bikfalvi, and L. Bello Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo Cancer Res. 63 2003 2499 2505
45. A.Y. Grahn, K.S. Bankiewicz, M. Dugich-Djordjevic, J.R. Bringas, P. Hadaczek, G.A. Johnson, S. Eastman, and M. Luz Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience J. Neurooncol. 95 2009 185 197
46. S.A. Grossman, C. Reinhard, O.M. Colvin, M. Chasin, R. Brundrett, R.J. Tamargo, and H. Brem The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers J. Neurosurg. 76 1992 640 647
47. D.W. Hansen Jr.; A. Stapelfeld, M.A. Savage, M. Reichman, D.L. Hammond, R.C. Haaseth, and H.I. Mosberg Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin J. Med. Chem. 35 1992 684 687
48. S.J. Hassenbusch, E.M. Nardone, V.A. Levin, N. Leeds, and D. Pietronigro Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial Neoplasia 5 2003 9 16
49. K.T. Heruth Medtronic SynchroMed drug administration system Ann. N. Y. Acad. Sci. 531 1988 72 75
50. K. Hynynen, N. McDannold, N. Vykhodtseva, and F.A. Jolesz Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits Radiology 220 2001 640 646
51. K. Hynynen, N. McDannold, N. Vykhodtseva, S. Raymond, R. Weissleder, F.A. Jolesz, and N. Sheikov Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery J. Neurosurg. 105 2006 445 454
52. L. Illum Transport of drugs from the nasal cavity to the central nervous system Eur. J. Pharm. Sci. 11 2000 1 18
53. R.K. Jain Transport of molecules in the tumor interstitium: a review Cancer Res. 47 1987 3039 3051
54. R.K. Jain Delivery of novel therapeutic agents in tumors: physiological barriers and strategies J. Natl. Cancer Inst. 81 1989 570 576
55. J. Johnston, S. Reich, A. Bailey, and J. Sluetz Shiley INFUSAID pump technology Ann. N. Y. Acad. Sci. 531 1988 57 65
56. K.D. Judy, A. Olivi, K.G. Buahin, A. Domb, J.I. Epstein, O.M. Colvin, and H. Brem Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas J. Neurosurg. 82 1995 481 486
57. H. Kebir, K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation Nat. Med. 13 2007 1173 1175
58. G.Y. Kim, B.M. Tyler, M.M. Tupper, J.M. Karp, R.S. Langer, H. Brem, and M.J. Cima Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model J. Control. Release 123 2007 172 178
59. P. Kleihues Klassifikation, Grading und genetisches Profil der Gliome. Schweizer Zeitschrift für Onkologie SZO 5 2007 5 9
60. P. Kleihues, D.N. Louis, B.W. Scheithauer, L.B. Rorke, G. Reifenberger, P.C. Burger, and W.K. Cavenee The WHO classification of tumors of the nervous system J. Neuropathol. Exp. Neurol. 61 2002 215 225 (discussion 226-219)
61. P. Kleihues, F. Soylemezoglu, B. Schauble, B.W. Scheithauer, and P.C. Burger Histopathology, classification, and grading of gliomas Glia 15 1995 211 221
62. M.T. Krauze, S.R. Vandenberg, Y. Yamashita, R. Saito, J. Forsayeth, C. Noble, J. Park, and K.S. Bankiewicz Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective Exp. Neurol. 210 2008 638 644
63. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81
64. J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, K. Cychutek, C. Koch-Brandt, and R. Alyautdin Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J. Drug Target 10 2002 317 325
65. S. Kunwar, S.M. Chang, M.D. Prados, M.S. Berger, J.H. Sampson, D. Croteau, J.W. Sherman, A.Y. Grahn, V.S. Shu, J.L. Dul, S.R. Husain, B.H. Joshi, C. Pedain, and R.K. Puri Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies Neurosurg. Focus 20 2006 E15
66. R.V. La Rocca, and H.M. Mehdorn Localized BCNU chemotherapy and the multimodal management of malignant glioma Curr. Med. Res. Opin. 25 2009 149 160
67. K.W. Leong, B.C. Brott, and R. Langer Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation, and release characteristics J. Biomed. Mater. Res. 19 1985 941 955
68. M.S. Lesniak, and H. Brem Targeted therapy for brain tumours Nat. Rev. Drug Discov. 3 2004 499 508
69. K.W. Li, W. Dang, B.M. Tyler, G. Troiano, T. Tihan, H. Brem, and K.A. Walter Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies Clin. Cancer Res. 9 2003 3441 3447
70. Y. Li, H.L. Ho Duc, B. Tyler, T. Williams, M. Tupper, R. Langer, H. Brem, and M.J. Cima In vivo delivery of BCNU from a MEMS device to a tumor model J. Control. Release 106 2005 138 145
71. W.B. Liechty, D.R. Kryscio, B.V. Slaughter, and N.A. Peppas Polymers for drug delivery systems Chem. Biomol. Eng. 1 2010 149 173
72. A.P. Lillis, L.B. Van Duyn, J.E. Murphy-Ullrich, and D.K. Strickland LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies Physiol. Rev. 88 2008 887 918
73. S.Y. Lin, L.F. Cheng, W.Y. Lui, C.F. Chen, and S.H. Han Tumoricidal effect of controlled-release polymeric needle devices containing adriamycin HCl in tumor-bearing mice Biomater. Artif. Cells Artif. Organs 17 1989 189 203
74. J.J. Lochhead, and R.G. Thorne Intranasal delivery of biologics to the central nervous system Adv. Drug Deliv. Rev. 2011
75. P.R. Lockman, J.M. Koziara, R.J. Mumper, and D.D. Allen Nanoparticle surface charges alter blood-brain barrier integrity and permeability J. Drug Target 12 2004 635 641
76. P. Lord, H. Allami, M. Davis, R. Diaz, P. Heck, and R. Fischell MiniMed technologies programmable implantable infusion system Ann. N. Y. Acad. Sci. 531 1988 66 71
77. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 114 2007 97 109
78. A.N. Mamelak Locoregional therapies for glioma Oncology (Williston Park) 19 2005 1803 1810 discussion 1810, 1816-1807, 1821-1802
79. Y. Mardor, Y. Roth, Z. Lidar, T. Jonas, R. Pfeffer, S.E. Maier, M. Faibel, D. Nass, M. Hadani, A. Orenstein, J.S. Cohen, and Z. Ram Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging Cancer Res. 61 2001 4971 4973
80. P. Menei, M. Boisdron-Celle, A. Croue, G. Guy, and J.P. Benoit Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats Neurosurgery 39 1996 117 123 discussion 123-114
81. P. Menei, V. Daniel, C. Montero-Menei, M. Brouillard, A. Pouplard-Barthelaix, and J.P. Benoit Biodegradation and brain tissue reaction to poly(d,l-lactide-co-glycolide) microspheres Biomaterials 14 1993 470 478
82. P. Menei, E. Jadaud, N. Faisant, M. Boisdron-Celle, S. Michalak, D. Fournier, M. Delhaye, and J.P. Benoit Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma Cancer 100 2004 405 410
83. P. Menei, M.C. Venier, E. Gamelin, J.P. Saint-Andre, G. Hayek, E. Jadaud, D. Fournier, P. Mercier, G. Guy, and J.P. Benoit Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study Cancer 86 1999 325 330
84. P.F. Morrison, and R.L. Dedrick Transport of cisplatin in rat brain following microinfusion: an analysis J. Pharm. Sci. 75 1986 120 128
85. H. Nakagawa, N. Maeda, T. Tsuzuki, T. Suzuki, A. Hirayama, E. Miyahara, and K. Wada Intracavitary chemotherapy with 5-fluoro-2′-deoxyuridine (FdUrd) in malignant brain tumors Jpn. J. Clin. Oncol. 31 2001 251 258
86. H. Nie, Y. Fu, and C.H. Wang Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors Biomaterials 31 2010 8732 8740
87. A.S. Oliver, G. Firth, and R.O. McKeran Studies on the intracerebral injection of vincristine free and entrapped within liposomes in the rat J. Neurol. Sci. 68 1985 25 30
88. A. Olivi, M.G. Ewend, T. Utsuki, B. Tyler, A.J. Domb, D.J. Brat, and H. Brem Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat Cancer Chemother. Pharmacol. 39 1996 90 96
89. W.M. Pardridge The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 2005 3 14
90. W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61
91. W.M. Pardridge Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses Bioconjug. Chem. 19 2008 1327 1338
92. W.M. Pardridge, J.L. Buciak, Y.S. Kang, and R.J. Boado Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium J. Clin. Invest. 92 1993 2224 2229
93. W.M. Pardridge, and W.H. Oldendorf Kinetics of blood-brain transport of hexoses Biochim. Biophys. Acta 382 1975 377 392
94. S.J. Patel, W.R. Shapiro, D.W. Laske, R.L. Jensen, A.L. Asher, B.W. Wessels, S.P. Carpenter, and J.S. Shan Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients Neurosurgery 56 2005 1243 1252 discussion 1252-1243
95. M.D. Prados, S.J.S. Schold, H.A. Fine, K. Jaeckle, F. Hochberg, L. Mechtler, M.R. Fetell, S. Phuphanich, L. Feun, T.J. Janus, K. Ford, and W. Graney A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma Neuro. Oncol. 5 2003 96 103
96. B. Rama, T. Mandel, J. Jansen, E. Dingeldein, and H.D. Mennel The intraneoplastic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets Acta Neurochir. (Wien) 87 1987 70 75
97. S.H. Ranganath, Y. Fu, D.Y. Arifin, I. Kee, L. Zheng, H.S. Lee, P.K. Chow, and C.H. Wang The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice Biomaterials 31 2010 5199 5207
98. S.H. Ranganath, I. Kee, W.B. Krantz, P.K. Chow, and C.H. Wang Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy Pharm. Res. 26 2009 2101 2114
99. D.R. Reddy, V.S. Prassad, and U.N. Das Intratumoural injection of gamma leinolenic acid in malignant gliomas J. Clin. Neurosci. 5 1998 36 39
100. L.D. Rhines, P. Sampath, F. DiMeco, H.C. Lawson, B.M. Tyler, J. Hanes, A. Olivi, and H. Brem Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma Neurosurgery 52 2003 872 879 discussion 879-880
101. V.G. Roullin, J.R. Deverre, L. Lemaire, F. Hindre, M.C. Venier-Julienne, R. Vienet, and J.P. Benoit Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres Eur. J. Pharm. Biopharm. 53 2002 293 299
102. A. Saija, P. Princi, D. Trombetta, M. Lanza, and A. De Pasquale Changes in the permeability of the blood-brain barrier following sodium dodecyl sulphate administration in the rat Exp. Brain Res. 115 1997 546 551
103. T. Sakane, C. Tanaka, A. Yamamoto, M. Hashida, H. Sezaki, H. Ueda, and H. Takagi The effect of polysorbate 80 on brain uptake and analgesic effect of d-kyotorphin Int. J. Pharma. 57 1989 77 83
104. J.T. Santini Jr.; A.C. Richards, R. Scheidt, M.J. Cima, and R. Langer Microchips as controlled drug-delivery devices Angew. Chem. Int. Ed. Engl. 39 2000 2396 2407
105. J.T. Santini Jr.; M.J. Cima, and R. Langer A controlled-release microchip Nature 397 1999 335 338
106. J.T. Santini Jr.; A.C. Richards, R.A. Scheidt, M.J. Cima, and R.S. Langer Microchip technology in drug delivery Ann. Med. 32 2000 377 379
107. A.J. Sawyer, J.M. Piepmeier, and W.M. Saltzman New methods for direct delivery of chemotherapy for treating brain tumors Yale J. Biol. Med. 79 2006 141 152
108. J.M. Scherrmann Drug delivery to brain via the blood-brain barrier Vascul. Pharmacol. 38 2002 349 354
109. T. Schumacher, S. Hofer, K. Eichhorn, M. Wasner, S. Zimmerer, P. Freitag, A. Probst, O. Gratzl, J.C. Reubi, R. Maecke, J. Mueller-Brand, and A. Merlo Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study Eur. J. Nucl. Med. Mol. Imaging 29 2002 486 493
110. J.A. Schwartzbaum, J.L. Fisher, K.D. Aldape, and M. Wrensch Epidemiology and molecular pathology of glioma Nat. Clin. Pract. Neurol. 2 2006 494 503 quiz 491 p following 516
111. S.L. Sendelbeck, and J. Urquhart Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion Brain Res 328 1985 251 258
112. V.E. Shashoua, and G.W. Hesse N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite Life Sci. 58 1996 1347 1357
113. J. Siepmann, and A. Gopferich Mathematical modeling of bioerodible, polymeric drug delivery systems Adv. Drug Deliv. Rev. 48 2001 229 247
114. E.P. Sipos, T.F. Witham, R. Ratan, P.C. Burger, J. Baraban, K.W. Li, S. Piantadosi, and H. Brem l-Buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model Neurosurgery 48 2001 392 400
115. P.B. Storm, J.L. Moriarity, B. Tyler, P.C. Burger, H. Brem, and J. Weingart Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy J. Neurooncol. 56 2002 209 217
116. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, and R.O. Mirimanoff Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 2005 987 996
117. R. Stupp, J.C. Tonn, M. Brada, and G. Pentheroudakis High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann. Oncol. 5 21 Suppl 2010 v190 v193
118. R.J. Tamargo, J.S. Myseros, J.I. Epstein, M.B. Yang, M. Chasin, and H. Brem Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain Cancer Res. 53 1993 329 333
119. C.H. Tator, A. Day, R. Ng, and L. Liberman Chemotherapy of an experimental glioma with nitrosoureas Cancer Res. 37 1977 476 481
120. T. Tomita Interstitial chemotherapy for brain tumors: review J. Neurooncol. 10 1991 57 74
121. A. Tsuji Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems NeuroRx 2 2005 54 62
122. A. Tsuji, and I.I. Tamai Carrier-mediated or specialized transport of drugs across the blood-brain barrier Adv. Drug Deliv. Rev. 36 1999 277 290
123. N. Tsuzuki, T. Hama, M. Kawada, A. Hasui, R. Konishi, S. Shiwa, Y. Ochi, S. Futaki, and K. Kitagawa Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety J. Pharm. Sci. 83 1994 481 484
124. K. Ulbrich, T. Hekmatara, E. Herbert, and J. Kreuter Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur. J. Pharm. Biopharm. 71 2009 251 256
125. US-National-Institute-of-Health, 2011. Clinical Trials, http://clinicaltrials.gov/, Bethesda. National Library of Medicine (US) (cited 19.03.11).
126. S. Valtonen, U. Timonen, P. Toivanen, H. Kalimo, L. Kivipelto, O. Heiskanen, G. Unsgaard, and T. Kuurne Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study Neurosurgery 41 1997 44 48 discussion 48-49
127. M.J. van den Bent, M.E. Hegi, and R. Stupp Recent developments in the use of chemotherapy in brain tumours Eur. J. Cancer 42 2006 582 588
128. S. Vinchon-Petit, D. Jarnet, S. Michalak, A. Lewis, J.P. Benoit, and P. Menei Local implantation of doxorubicin drug eluting beads in rat glioma Int. J. Pharm. 402 2010 184 189
129. L.A. Wade, and R. Katzman Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection Am. J. Physiol. 228 1975 352 359
130. E. Wagner, D. Curiel, and M. Cotton Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis Adv. Drug Deliv. Rev. 14 1994 113 135
131. S. Wagner, A. Zensi, S.L. Wien, S.E. Tschickardt, W. Maier, T. Vogel, F. Worek, C.U. Pietrzik, J. Kreuter, and H. von Briesen Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model PLoS One 7 2012 e32568
132. M.D. Walker, E. Alexander Jr.; W.E. Hunt, C.S. MacCarty, M.S. Mahaley Jr.; J. Mealey Jr.; H.A. Norrell, G. Owens, J. Ransohoff, C.B. Wilson, E.A. Gehan, and T.A. Strike Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial J. Neurosurg. 49 1978 333 343
133. K.A. Walter, M.A. Cahan, A. Gur, B. Tyler, J. Hilton, O.M. Colvin, P.C. Burger, A. Domb, and H. Brem Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma Cancer Res. 54 1994 2207 2212
134. K.A. Walter, R.J. Tamargo, A. Olivi, P.C. Burger, and H. Brem Intratumoral chemotherapy Neurosurgery 37 1995 1128 1145
135. P.P. Wang, J. Frazier, and H. Brem Local drug delivery to the brain Adv. Drug Deliv. Rev. 54 2002 987 1013
136. M. Weaver, and D.W. Laske Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas J. Neurooncol. 65 2003 3 13
137. S.J. Weber, D.L. Greene, S.D. Sharma, H.I. Yamamura, T.H. Kramer, T.F. Burks, V.J. Hruby, L.B. Hersh, and T.P. Davis Distribution and analgesia of [3H][D-Pen2 D-Pen5]enkephalin and two halogenated analogs after intravenous administration J. Pharmacol. Exp. Ther. 259 1991 1109 1117
138. P.Y. Wen American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section Expert Rev. Anticancer Ther. 10 2010 1367 1369
139. M. Westphal, D.C. Hilt, E. Bortey, P. Delavault, R. Olivares, P.C. Warnke, I.R. Whittle, J. Jaaskelainen, and Z. Ram A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro. Oncol. 5 2003 79 88
140. M. Westphal, and K. Lamszus The neurobiology of gliomas: from cell biology to the development of therapeutic approaches Nat. Rev. Neurosci. 12 2011 495 508
141. M. Westphal, Z. Ram, V. Riddle, D. Hilt, and E. Bortey Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochir. (Wien) 148 2006 269 275 discussion 275
142. W. Wick NOA - Neuroonkologische Arbeitsgemeinschaft N. Koordinierungsstelle, Gliome 2008 Heidelberg, http://www.neuroonkologie.de/ index.php?id=50
143. J.A. Williams, L.E. Dillehay, K. Tabassi, E. Sipos, C. Fahlman, and H. Brem Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma J. Neurooncol. 32 1997 181 192
144. S. Wohlfart, A.S. Khalansky, C. Bernreuther, M. Michaelis, J. Cinatl Jr.; M. Glatzel, and J. Kreuter Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles Int. J. Pharm. 415 2011 244 251
145. S. Wohlfart, A.S. Khalansky, S. Gelperina, D. Begley, and J. Kreuter Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier J. Control. Release 154 2011 103 107
146. W. Yang, R.F. Barth, G. Wu, T. Huo, W. Tjarks, M. Ciesielski, R.A. Fenstermaker, B.D. Ross, C.J. Wikstrand, K.J. Riley, and P.J. Binns Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors J. Neurooncol. 95 2009 355 365
147. D. Yin, J. Forsayeth, and K.S. Bankiewicz Optimized cannula design and placement for convection-enhanced delivery in rat striatum J. Neurosci. Methods 187 2010 46 51
148. M. Yokosawa, Y. Sonoda, S. Sugiyama, R. Saito, Y. Yamashita, M. Nishihara, T. Satoh, T. Kumabe, M. Yokoyama, and T. Tominaga Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts Tohoku J. Exp. Med. 221 2010 257 264
149. S. Yoshida, R. Tanaka, N. Takai, and K. Ono Local administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with malignant brain tumors Cancer Res. 48 1988 5011 5016
150. Y. Zhang, Y.F. Zhang, J. Bryant, A. Charles, R.J. Boado, and W.M. Pardridge Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer Clin. Cancer Res. 10 2004 3667 3677
151. Y.H. Zhang, Z.J. Yue, H. Zhang, G.S. Tang, Y. Wang, and J.M. Liu Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model Eur. J. Pharm. Biopharm. 76 2010 371 375